Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0002 Transporter Info
Gene Name ABCC2
Transporter Name Multidrug resistance-associated protein 2
Gene ID
1244
UniProt ID
Q92887
Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota

   Genus: Bifidobacterium

     Bifidobacterium adolescentis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of ABCC2 expression in colon cancer condition [1]

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The Bifidobacterium adolescentis has been reported to decrease the expression of the drug transporter ABCC2.

     Bifidobacterium animalis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC2 expression in diabetes condition [2] , [3]

Studied Phenotype

 Diabetes [ICD11: 5A10-5A14]

Studied Tissue

 Ileum

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The Bifidobacterium animalis subsp. lactis has been reported to increase the expression of the drug transporter ABCC2.

Bacteria: Bacillota

   Genus: Clostridium

     Clostridium sporogenes 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC2 expression in conventional mice compared with germ-free mice [4] , [5]

Regulating Factor
3-Indolepropionic acid , Indole

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Kidney

In Vivo Model

 Swiss Webster germ-free mice

In Vitro Model

 Human kidney human embryonic kidney 293T cells (HEK 293T)

Detailed Description

 The metabolite 3-indolepropionic acid and indole generated from the metabolism of indole by the Clostridium sporogenes has been reported to increase the expression of the drug transporter ABCC2.

   Genus: Lacticaseibacillus

     Lacticaseibacillus rhamnosus 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC2 expression in diabetes condition [2] , [3]

Studied Phenotype

 Diabetes [ICD11: 5A10-5A14]

Studied Tissue

 Ileum

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The Lacticaseibacillus rhamnosus has been reported to increase the expression of the drug transporter ABCC2.

   Genus: Lactobacillus

     Lactobacillus acidophilus 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC2 expression in diabetes condition [2] , [3]

Studied Phenotype

 Diabetes [ICD11: 5A10-5A14]

Studied Tissue

 Ileum

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The Lactobacillus acidophilus has been reported to increase the expression of the drug transporter ABCC2.

   Genus: Ligilactobacillus

     Ligilactobacillus murinus 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of ABCC2 expression in colon adenocarcinoma condition [6]

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vivo Model

 Sprague-Dawley specific pathogen free rats

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The Ligilactobacillus murinus has been reported to decrease the expression of the drug transporter ABCC2.

Bacteria: Pseudomonadota

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of ABCC2 expression in colon cancer condition [1]

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The Escherichia coli Nissle 1917 has been reported to decrease the expression of the drug transporter ABCC2.

Bacteria: Verrucomicrobiota

   Genus: Akkermansia

     Akkermansia muciniphila 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC2 expression in metabolic dysfunction-associated fatty liver disease condition [7]

Studied Phenotype

 Metabolic dysfunction-associated fatty liver disease [ICD11: DB95]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6 mice

Detailed Description

 The Akkermansia muciniphila ATCC BAA-835 has been reported to increase the expression of the drug transporter ABCC2.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 15 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of ABCC2 expression in the health condition [8] , [9]

Regulating Factor
2,3,7,8-tetrachlorodibenzofuran

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite 2,3,7,8-tetrachlorodibenzofuran generated from the metabolism of dietary dough pills by the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 2

 Down regulating of ABCC2 expression in the health condition [10]

Regulating Factor
Urolithin A

Studied Tissue

 Colon

In Vivo Model

 NRGS mice

In Vitro Model

 Human colon carcinoma cells (HCT-116)

Detailed Description

 The metabolite urolithin a generated from the metabolism of dietary polyphenols by the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 3

 Down regulating of ABCC2 expression in conventional mice compared with germ-free mice [8] , [11]

Regulating Factor
Tauro-beta-muricholic acid

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Ileum

In Vivo Model

 Swiss Webster mice

Detailed Description

 The metabolite tauro-beta-muricholic acid generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 4

 Up regulating of ABCC2 expression in colon cancer condition [12]

Regulating Factor
Chenodeoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 5

 Up regulating of ABCC2 expression in colon cancer condition [12]

Regulating Factor
Deoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (HT-29)

Detailed Description

 The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 6

 Up regulating of ABCC2 expression in the health condition [13] , [14]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 7

 Up regulating of ABCC2 expression in the health condition [13] , [14]

Regulating Factor
Bile acid (Cholic acid)

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 8

 Up regulating of ABCC2 expression in the health condition [13] , [14]

Regulating Factor
Bile acid (Deoxycholic acid)

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 9

 Up regulating of ABCC2 expression in the health condition [13] , [14]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 10

 Up regulating of ABCC2 expression in the health condition [13] , [14]

Regulating Factor
Bile acid (Lithocholic acid)

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC2.

       Microbe Influence 11

 Down regulating of ABCC2 expression in conventional mice compared with germ-free mice [15] , [16]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J germ-free mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 12

 Down regulating of ABCC2 expression in conventional mice compared with germ-free mice [17]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6 germ-free/conventionally-raised mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 13

 Down regulating of ABCC2 expression in conventional mice compared with germ-free mice [18] , [19]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Small intestine

In Vivo Model

 C57BL/6N mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 14

 Down regulating of ABCC2 expression in conventional mice compared with germ-free mice [20]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.

       Microbe Influence 15

 Down regulating of ABCC2 expression in conventional mice compared with germ-free mice [20]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCC2.
References
1 Causative Role of Anoxic Environment in Bacterial Regulation of Human Intestinal Function. Cell Mol Bioeng. 2022 Sep 16;15(5):493-504.
2 The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 2021 Jul;11(7):1789-1812.
3 Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats. Arch Drug Inf. 2008 Jul;1(1):35-41.
4 Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting. Drug Metab Dispos. 2018 May;46(5):503-513.
5 Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014 Aug 21;41(2):296-310.
6 Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats. Front Microbiol. 2020 Apr 24;11:597.
7 Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021 Jan-Dec;13(1):1-19.
8 Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos. 2015 Oct;43(10):1505-21.
9 Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect. 2015 Jul;123(7):679-88.
10 Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis. Theranostics. 2022 Jul 18;12(12):5574-5595.
11 Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013 Feb 5;17(2):225-35.
12 Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein. Mol Pharm. 2018 Dec 3;15(12):5711-5727.
13 Bile Acids Activated Receptors Regulate Innate Immunity. Front Immunol. 2018 Aug 13;9:1853.
14 Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice. Drug Metab Dispos. 2015 Oct;43(10):1544-56.
15 Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019 Sep;12(9):421-429.
16 RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice. Drug Metab Dispos. 2015 Oct;43(10):1572-80.
17 Coordinate regulation of long non-coding RNAs and protein-coding genes in germ-free mice. BMC Genomics. 2018 Nov 21;19(1):834.
18 New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. Clin Pharmacol Ther. 2022 Sep;112(3):540-561.
19 Proteomic analysis of small intestinal epithelial cells in antibiotic-treated mice: Changes in drug transporters and metabolizing enzymes. Drug Metab Pharmacokinet. 2019 Apr;34(2):159-162.
20 RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice. Drug Metab Dispos. 2017 Dec;45(12):1225-1238.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.